Origin of cross-reactive autoimmunity in primary biliary cirrhosis

Liver International

Volumn 26, Issue 6, 2006, Pages 633-635

  Bogdanos, Dimitrios Petrou ^a   Vergani, Diego ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOACID; 2 OXOACID DEHYDROGENASE; AUTOANTIBODY; BINDING PROTEIN; EPITOPE; MITOCHONDRION ANTIBODY; OXOGLUTARATE DEHYDROGENASE; PROTEIN SUBUNIT; PROTEIN X; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE COMPLEX E1 ALPHA; PYRUVATE DEHYDROGENASE COMPLEX E1 BETA; PYRUVATE DEHYDROGENASE COMPLEX E2; PYRUVATE DEHYDROGENASE COMPLEX E3; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; AUTOIMMUNITY; B LYMPHOCYTE; BILIARY CIRRHOSIS; BINDING SITE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CROSS REACTION; EDITORIAL; HOST RESISTANCE; HUMAN; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; T LYMPHOCYTE; TARGET CELL; WESTERN BLOTTING;

AUTOANTIBODIES; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA; MODELS, IMMUNOLOGICAL;

EID: 33745610428     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01291.x     Document Type: Editorial

References (26)

1. Janeway C A Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54 (Part 1): 1-13.
2. Janeway C A Jr. How the immune system protects the host from infection. Microb Infect 2001; 3(13): 1167-71.
3. Jacobson D L, Gange S J, Rose N R, Graham N M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84(3): 223-43.
4. Cooper G S, Stroehla B C. The epidemiology of autoimmune diseases. Autoimmun Rev 2003; 2(3): 119-25.
5. Smith H R, Steinberg A D. Autoimmunity - a perspective. Annu Rev Immunol 1983; 1: 175-210.
6. Rose N R. Mechanisms of autoimmunity. Semin Liver Dis 2002; 22(4): 387-94.
7. Mackay I R, Rowley M J. Autoimmune epitopes: Autoepitopes. Autoimmun Rev 2004; 3 (7-8): 487-92.
8. Lehmann P V, Forsthuber T, Miller A, Sercarz E E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358(6382): 155-7.
9. Vanderlugt C L, Miller S D. Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol 2002; 2(2): 85-95.
10. Kaplan M M, Gershwin M E. Primary biliary cirrhosis. N Engl J Med 2005; 353(12): 1261-73.
11. Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350(9081): 875-9.
12. Bogdanos D P, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis 2003; 7(4): 759-77, vi.
13. Mitchison H C, Bassendine M F, Hendrick A, et al. Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis? Hepatology 1986; 6 (6): 1279-84.
14. Metcalf J V, Mitchison H C, Palmer J M, Jones D E, Bassendine M F, James O F. Natural history of early primary biliary cirrhosis. Lancet 1996; 348 (9039): 1399-402.
15. Prince M, Chetwynd A, Newman W, Metcalf J V, James O F. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years. Gastroenterology 2002; 123(4): 1044-51.
16. Gershwin M E, Mackay I R. Primary biliary cirrhosis: Paradigm or paradox for autoimmunity. Gastroenterology 1991; 100(3): 822-33.
17. Bogdanos D P, Baum H, Grasso A, et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 2004; 40(1): 31-9.
18. Vergani D, Bogdanos D P, Baum H. Unusual suspects in primary biliary cirrhosis. Hepatology 2004; 39(1): 38-41.
19. Bogdanos D P, Baum H, Okamoto M, et al. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 2005; 42(2): 458-65.
20. Bogdanos D P, Pares A, Baum H, et al. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun 2004; 22(4): 353-62.
21. Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim Biophys Acta 1995; 1271 (1): 111-21.
22. Krams S M, Surh C D, Coppel R L, Ansari A, Ruebner B, Gershwin M E. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989; 9(3): 411-6.
23. Masanage T, Watanane Y, Leung P S C, et al. PBC-like lesion is induced and maintained by immunization with recombinant PDC-E2 BCKD-E2 hybrid molecule and liposaccharide injection in neonatally thymectomized mice. Gastroenterology 1994; 110: A1260.
24. Dubel L, Tanaka A, Leung P S, et al. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 1999; 29(4): 1013-8.
25. Palmer J M, Jones D E, Quinn J, McHugh A, Yeaman S J. Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology 1999; 30(1): 21-6.
26. McHugh A, Robe A J, Palmer J M, Jones D E, PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosis. Liver Int 2006; 26: 406-13.